Article
In the interest of ensuring the highest levels of safety for both surgeon and patient, two microkeratome manufacturers are initiating voluntary corrective action for two of their devices.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.